We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$65.6B
AUM Growth
+$9.58B
Cap. Flow
+$6.37B
Cap. Flow %
9.71%
Top 10 Hldgs %
7.83%
Holding
4,198
New
794
Increased
1,441
Reduced
1,175
Closed
737

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$208M
2
CXO
CONCHO RESOURCES INC.
CXO
+$177M
3
CCI icon
Crown Castle
CCI
+$168M
4
WMT icon
Walmart Inc
WMT
+$167M
5
ETR icon
Entergy
ETR
+$157M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 13.18%
3 Healthcare 11.51%
4 Industrials 10.45%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REV
3101
DELISTED
Revlon, Inc.
REV
$270K ﹤0.01%
+11,014
New +$213K
PKO
3102
DELISTED
Pimco Income Opportunity Fund
PKO
$270K ﹤0.01%
+10,244
New +$270K
ATRI
3103
DELISTED
Atrion Corp
ATRI
$269K ﹤0.01%
400
-74
-16% -$47.5K
KYE
3104
DELISTED
Kayne Anderson Energy
KYE
$269K ﹤0.01%
24,185
+12,740
+111% +$137K
JHG
3105
DELISTED
Janus Henderson
JHG
$268K ﹤0.01%
+7,701
New +$262K
NMR icon
3106
Nomura Holdings
NMR
$28.5B
$268K ﹤0.01%
48,200
-88,301
-65% -$506K
KEYW
3107
DELISTED
The KEYW Holding Corporation
KEYW
$268K ﹤0.01%
+35,202
New +$286K
SPLV icon
3108
Invesco S&P 500 Low Volatility ETF
SPLV
$7.11B
$267K ﹤0.01%
5,840
-6,232
-52% -$282K
LE icon
3109
Lands' End
LE
$377M
$266K ﹤0.01%
20,187
-10,418
-34% -$136K
VANI icon
3110
Vivani Medical
VANI
$124M
$265K ﹤0.01%
9,187
-2,073
-18% -$58K
TVRD
3111
Tvardi Therapeutics
TVRD
$23.7M
$265K ﹤0.01%
538
-188
-26% -$94.1K
IGR
3112
CBRE Global Real Estate Income Fund
IGR
$704M
$264K ﹤0.01%
33,400
+19,300
+137% +$150K
CRK icon
3113
Comstock Resources
CRK
$4.19B
$263K ﹤0.01%
+43,290
New +$281K
STK
3114
Columbia Seligman Premium Technology Growth Fund
STK
$901M
$262K ﹤0.01%
+11,709
New +$259K
CMRX
3115
DELISTED
Chimerix, Inc.
CMRX
$262K ﹤0.01%
49,928
-23,735
-32% -$117K
CPL
3116
DELISTED
CPFL Energia S.A.
CPL
$262K ﹤0.01%
+15,267
New +$260K
LILAK icon
3117
Liberty Latin America Class C
LILAK
$1.64B
$261K ﹤0.01%
13,108
-228,733
-95% -$4.89M
RMR icon
3118
The RMR Group
RMR
$336M
$261K ﹤0.01%
5,087
-9,182
-64% -$454K
TRIP icon
3119
TripAdvisor
TRIP
$1.19B
$259K ﹤0.01%
6,387
-149,879
-96% -$6.09M
ATXI
3120
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$258K ﹤0.01%
+42
New +$308K
VIS icon
3121
Vanguard Industrials ETF
VIS
$8.15B
$257K ﹤0.01%
+1,911
New +$247K
XOMA
3122
DELISTED
Xoma
XOMA
$257K ﹤0.01%
+13,076
New +$146K
CTSO icon
3123
Cytosorbents Corp
CTSO
$23.3M
$256K ﹤0.01%
+41,217
New +$210K
CASC
3124
DELISTED
Cascadian Therapeutics, Inc.
CASC
$255K ﹤0.01%
+62,300
New +$238K
NEWS
3125
DELISTED
NewStar Financial, Inc.
NEWS
$255K ﹤0.01%
+21,700
New +$237K

Similar funds

Israel Englander's Q3 2017 Portfolio in Review

As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.

  • Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
  • Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
  • Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
  • Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
  • Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
  • Israel Englander opened 794 new positions and closed 737 in Q3 2017.
  • Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.

Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.